Join the Institute for Science & Policy, the Denver Museum of Nature & Science, and the Colorado School of Public Health every other Monday at 8:30 a.m. MT for a free webinar, each bringing a new expert perspective to the COVID-19 challenge.
Miss an installment? Recordings and recaps will be posted 24-36 hours after the live broadcast.
COVID-19: Open Forum
A Collaboration of the Colorado School of Public Health and the Denver Museum of Nature & Science
Monday, October 26 at 8:30 a.m. MT
Register for the free webinar
Scientists, policymakers, and medical professionals have learned quite a bit about COVID-19 since the early days of the pandemic. Nevertheless, many of the biggest questions – How effective are tests? How do we really know if social distancing is working? - remain salient to our public health response today and can now be updated with new data and new insights. In our next episode, we’re turning the floor over to you for a full 45 minutes of audience-driven Q&A. From testing to treatments to tracking the spread, what’s on your mind and what would you still like to know more about?
Join us Monday, October 26 at 8:30 a.m. MT as we welcome back returning guests Michelle Barron, MD, Professor of Medicine-Infectious Disease at the University of Colorado School of Medicine, and Jude Bayham, Assistant Professor of Agricultural & Resource Economics at Colorado State University. They’ll be joined by C. Neill Epperson, MD, Chair of Psychiatry at the University of Colorado School of Medicine, and Jonathan Samet, MD, MS, Professor of Epidemiology and Environmental and Occupational Health and Dean of the Colorado School of Public Health for a session dedicated entirely to your questions.
This free public webinar is presented by the Colorado School of Public Health, the Denver Museum of Nature & Science, and the Institute for Science & Policy. The session will also be streamed on Facebook.
In our previous episode, we gained some national perspective on lessons learned during the first six months of COVID-19. On Monday, October 12, we’re turning our focus to Colorado. Since March, state public health officials have been grappling with the challenges of the pandemic and implementing new policies at a rapid pace. How has Colorado’s response evolved since that first wave of cases in the spring, and what insights have we gained about communication, testing, tradeoffs, and the efficacy of public health guidance?
Presenters: Jill Hunsaker Ryan, MPH, Executive Director of the Colorado Department of Public Health and Environment, and Kacey Wulff, Senior Advisor for COVID-19 Response, Resilience, and Recovery in the Office of Governor Jared Polis.
By mid-March, the ongoing spread of COVID-19 began to affect American life in a big way. The NBA suspended its season. Flights, concerts, and conferences were abruptly cancelled. States began to implement full or partial closures of non-essential businesses. Scientists and public health officials raced to issue guidance, even as much about the disease remained unknown. Now, six months later, our collective knowledge of SARS-CoV-2 has evolved dramatically, both from an epidemiological perspective and a societal one. What have we learned so far about the effects of policy, the speed of research, and public trust in science that could help us in 2021?
Presenter: Georges C. Benjamin, MD, Executive Director of the American Public Health Association
The race for a COVID-19 vaccine has commanded international focus since the pandemic began, so where do things stand now that autumn is approaching? A number of vaccine candidates, including some from the federal government’s Operation Warp Speed initiative, have begun clinical trials. Experts have not ruled out the possibility of FDA approval in record time and mass distribution by early 2021. But as research proceeds at a breakneck pace and vaccines become a political hot button in the lead up to the November election, scientists must delicately balance speed, efficacy, and safety. What will the first “successful” vaccine look like, and which criteria should be used to make that determination?
Presenter: Peter Hotez, Dean of the National School of Tropical Medicine at Baylor College of Medicine.
When it comes to the COVID-19 pandemic, scientists and public health officials are still working toward consensus on a fundamental question: To what extent is transmission of the responsible virus (SARS-CoV-2) airborne and what is the size range of infectious particles? Research has shown that an infected person expels viral particles in “droplets” via sneezing or coughing and that masks, social distancing, and generally being outdoors can reduce the spread of the disease. People also produce small particles that may also be infectious. But much remains uncertain about how long those infectious droplets and smaller particles linger in the air and how far they might travel, particularly in enclosed settings. So what does the current science tell us about exposure indoors? And are there mitigation strategies that homes, schools, and businesses should think about adopting as winter approaches?
Presenters: Shelly Miller, Professor of Mechanical Engineering at the University of Colorado Boulder, and Jonathan Samet, Professor of Epidemiology and Environmental and Occupational Health and Dean of the Colorado School of Public Health.
COVID-19 has sent shock waves through every sector of the U.S. economy, leaving businesses to navigate an uncertain future and millions of workers out of a job. While some industries look poised to bounce back quickly once the pandemic recedes, others may struggle and/or be permanently reshaped. What will meaningful recovery look like in Colorado, and when might it arrive?
Presenters: Kelly Brough, President and CEO of the Denver Metro Chamber of Commerce and Richard Wobbekind, Associate Dean for Business & Government Relations at the University of Colorado Boulder’s Leeds School of Business.
August 17: COVID-19 in Latin America
Watch the full recording
Even as the coronavirus has come under some measure of control in other parts of the globe, Latin America has become a hotspot. As the pandemic has battered the region, it has jeopardized public health, devastated commerce, and exacerbated longstanding inequalities that threaten to derail years of social progress. Countries such as Mexico and Brazil are facing overwhelming caseloads, high death rates, and double-digit economic contractions. Latin America’s worsening COVID-19 plight will have ripple effects on the world stage for years to come, and it can also offer important lessons about global health policy as we re-evaluate our own preparedness for future disasters.
Presenters: Dr. Edwin Asturias, Professor of Pediatrics-Infectious Disease at the CU School of Medicine, Professor of Epidemiology and Director of Latin American Projects for the Center for Global Health at the Colorado School of Public Health and Dr. Mauricio Hernández Ávila, Director of Economic and Social Benefits at the Mexican Institute of Social Security (IMSS).
August 10: COVID-19 & Mental Health
Watch the full recording
For many Americans, the stresses of COVID-19 extend well beyond the virus itself. We may be feeling isolated after months of physical distancing, fearful for our own personal safety, or anxious about household finances and the state of the economy. Frustration, helplessness, depression, exhaustion, anger, grief ─ our emotions can run the gamut, and no two people will ever navigate trauma in quite the same way. Mental health is a difficult subject, one that’s often uncomfortable to broach even with those we’re closest with. But even as the country works to bring the coronavirus under control from an epidemiological perspective, medical caregivers caution that we cannot ignore the long-lasting psychological effects of living through a world-altering pandemic. So what can we do to help ourselves, our families, and our neighbors arrive at healthy outcomes during this period of extreme stress and uncertainty?
Presenters: Mercedez Lang and Michelle Tijerina, both practitioners and ambassadors for the Healthy Living Team at the Mental Health Center of Denver.
COVID-19 isn’t the first virus to make the leap from animals to humans, and if history is any guide, it won’t be the last. Novel zoonotic diseases can persist benignly inside an animal host for years, waiting patiently for an opportunity to jump to a new species and wreak havoc. We’ve seen other high-profile examples of these “spillover” events in recent decades, notably AIDS, Ebola, and SARS. Scientists have been working to better understand these transmission pathways in order to warn of new emerging threats. But there is still much to learn. Which conditions allow an animal-borne virus like COVID-19 to take hold in human populations? And what have researchers learned that might help us prevent future global outbreaks?
Presenters: Brian Foy, PhD and Tony Schountz, PhD, both Professors in the Department of Microbiology, Immunology, and Pathology at Colorado State University.
Amidst a nationwide resurgence of COVID-19, Colorado scientists, health officials, and policymakers continue to closely monitor the disease’s progression within the state. Mountain towns have seen an influx of summer visitors, bringing some economic relief, but also a rise in caseloads. Counties are continuing to navigate physical distancing guidelines for businesses while warily looking ahead to opening schools in the fall. Face mask usage — recently mandated statewide — remains a political flashpoint. Five months into the coronavirus epidemic, what have we learned and where does Colorado go from here?
Presenters: Jonathan Samet, MD, MS, Professor of Epidemiology and Environmental and Occupational Health and Dean of the Colorado School of Public Health; John M. Douglas, Jr., MD, Executive Director of the Tri-County Health Department; and Karen Koenemann, Public Health Director for Pitkin County.
COVID-19 has illustrated structural inequities in the American healthcare system that have persisted for centuries. Black Americans are dying of the virus at a higher rate than whites, despite making up a smaller percentage of the population. Majority-minority communities commonly lack access to testing sites and other medical resources. Black, Latino, and Native Americans are likelier to suffer from preventable illnesses and pre-existing health conditions, leaving them at greater risk during an epidemic. How did this come to be? And how can policymakers, scientists, health practitioners, and citizens help address these long-standing public health trends and move toward a more just and equitable system for all?
Part One presenters (July 13):
Fernando Holguin, MD, Director of the Latino Research & Policy Center at the Colorado School of Public Health and Professor of Medicine-Pulmonary Sciences & Critical Care and Director of Asthma Clinical and Research Programs at the University of Colorado School of Medicine
Cerise Hunt, PhD, MSW, Director for the Center for Public Health Practice and Assistant Professor in Community and Behavioral Health at Colorado School of Public Health
Spero M. Manson, PhD, (Pembina Chippewa), Distinguished Professor of Public Health and Psychiatry, Director of the Centers for American Indian and Alaska Native Health, and the Colorado Trust Chair in American Indian Health within the Colorado School of Public Health
Part Two presenters: (July 20):
Alisha Brown, MNM, Senior Vice President, The Foundation for Sustainable Urban Communities and Director of the be well Health and Wellness Initiative
Michael Cortés, MSW, MPP, PhD, Executive Director of the Colorado Latino Leadership, Advocacy & Research Organization (CLLARO)
Jennifer Ho, PhD, Director of the Center for Humanities & the Arts and Professor of Ethnic Studies at the University of Colorado Boulder and President of the Association of Asian American Studies
The COVID-19 pandemic has raised a number of complicated ethical questions for society, including if and when it is acceptable to restrict individual liberties to protect the public by enforcing quarantines, face masks, or event cancellations. Hospitals have had to confront the possibility of severe shortages and the potential need for rationing. And all of us have had to think carefully about our own personal and professional responsibilities in how we respond. Tensions between individual risk and communal safety have created flashpoints in communities, exposing broader disagreements over core values and priorities. In light of this, how can policymakers, scientists, and citizens best navigate these murky moral waters? And what do we owe to ourselves and to each other as human beings in the face of this global crisis?
Presenter: Matthew Wynia, MD, MPH, FACP, Professor of Medicine and Public Health and Director of the Center for Bioethics and Humanities at the University of Colorado Anschutz Medical Campus.
As COVID-19 spread rapidly around the world, so too did myths, exaggerations, and outright falsehoods. The flood of misinformation was often powerful enough to shape public perception and policy decisions. But in the face of ever-evolving guidance from experts and wall-to-wall media saturation, how can the public sort fact from fiction? What makes a particular source reliable – or not?
Presenters: Steven Goodman, MD, MHS, PhD, Associate Dean of Clinical and Translational Research and Professor of Epidemiology and Population Health and Medicine at Stanford University, and Elizabeth Skewes, PhD, Department of Journalism Chair and Associate Professor in the College of Media, Communication and Information at the University of Colorado Boulder.
Summer is typically the season of camping, grilling, and lounging by the pool, but some of our favorite warm weather activities could look and feel very different this year due to ongoing COVID-19 precautions. So what should Coloradans expect over the next few months? Is it safe to send kids to camp? Will I be able to go swimming? Will vacation destinations be open for business? And will the coronavirus make a comeback?
Presenters: Rachel Herlihy, MD, MPH/MSPH, State Epidemiologist for the Colorado Department of Public Health & Environment and Jonathan Samet, MD, MS, Professor of Epidemiology and Environmental and Occupational Health and Dean of the Colorado School of Public Health.
Colorado’s research community has responded swiftly to the COVID-19 challenge, with new projects already underway on vaccine development, diagnostic tools, biomedical countermeasures, and food system impact mitigation. Historically, technological investment has aided our response against diseases before they emerge, in the midst of outbreaks, and during the lengthy global recovery. Many exciting avenues of study are happening in our Colorado backyard right now. But what does applied research really look like, and when might we see the impacts?
Presenter: Alan Rudolph, Ph.D., MBA, Vice President for Research at Colorado State University.
Coloradans have increased their time spent at home since mid-March following statewide policy interventions implemented by Governor Polis and increased social distancing guidelines set by essential businesses. Using digital trace data, scientists have been able to study general patterns in population mobility during the COVID-19 pandemic. The results find noteworthy trends, including variation across different areas of the state; a voluntary reduction in movement even before Stay-at-Home orders took effect; and recent reversals in the overall amount of time spent in public.
COVID-19: On the Front Lines
Read the recap and watch the full recording
As the battle against COVID-19 unfolds each day in America’s hospitals, doctors, nurses, respiratory therapists, and other caregivers are working tirelessly to diagnose, treat, and improve patient outcomes. Their selfless efforts in the face of an unprecedented epidemic have earned commendation nationwide, and their stories from the front lines help us look beyond statistics to understand the true human impact of the disease.
Presenters: Marc Moss, MD, the Roger S. Mitchell Professor of Medicine and Head of the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado School of Medicine and Traci L. Priebe, RN, BSN, CCRN, Charge Nurse in the medical ICU at the University of Colorado Hospital.
For weeks, the availability and accessibility of COVID-19 testing has dominated the national discourse. Who can get tested? How quickly do the results come back? Is there enough widespread testing to identify and contain new hotspots? In such a rapidly-shifting landscape, guidance can change quickly, leaving the public with more questions than answers.
Presenter: Kyle M. Brown, Ph.D., Deputy for Mass Testing and Isolation Support on Colorado’s COVID Innovation Response Team
The search for a COVID-19 vaccine has taken center stage, with all eyes on scientists’ efforts to develop safe and effective treatments at a breakneck pace. With so much of the world’s population still susceptible to infection, a return to any semblance of social normalcy may hinge on widespread inoculations, therapeutic solutions, and herd immunity. But what will a successful vaccine rollout look like, and when might it arrive?
Controlling the COVID-19 Epidemic in Colorado
Read the recap and watch the full video
As Colorado moves into the next phase of its COVID-19 response, many residents are wondering: Now what? Is it safe to go back to work? Will there be a second wave of infections? Which epidemiological models are useful? And what can the data tell us about the weeks and months to come?
Presenter: Jonathan Samet, MD, MS, Professor of Epidemiology and Environmental and Occupational Health and Dean of the Colorado School of Public Health
The Institute for Science & Policy is committed to publishing diverse perspectives in order to advance civil discourse and productive dialogue. Views expressed by contributors do not necessarily reflect those of the Institute, the Denver Museum of Nature & Science, or its affiliates.